BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND IGH AND Treatment
7 results:

  • 1. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
    Huang F; Ruan Y; He X; Lian H; Yang J
    World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma.
    Adamia S; Bhatt S; Wen K; Chyra Z; Fell GG; Tai YT; Pioso MS; Abiatari I; Letai A; Dorfman DM; Hideshima T; Anderson KC
    Leukemia; 2022 Apr; 36(4):1088-1101. PubMed ID: 35082402
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Primary breast CD20-positive extranodal NK/T cell lymphoma with stomach involvement: a case report and literature review.
    Zhang Y; Wang K; Tan Q; Yang K; Wu D; Xu Y; Zhao X; Jiang Z
    Diagn Pathol; 2021 Nov; 16(1):103. PubMed ID: 34749754
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications.
    Nybakken GE; Bala R; Gratzinger D; Jones CD; Zehnder JL; Bangs CD; Cherry A; Warnke RA; Natkunam Y
    PLoS One; 2016; 11(3):e0151735. PubMed ID: 26991267
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Primary high-grade B-cell lymphoma of the breast with concurrent igh-BCL2 and MYC-IGL translocations in an adolescent patient.
    Liang X; Jones A; Giller RH; Swisshelm K; McGavran L; Meltesen L; Carstens B; McGranahan AN; Albano EA
    Pediatr Dev Pathol; 2011; 14(5):402-6. PubMed ID: 21491965
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up.
    Raderer M; Streubel B; Woehrer S; Puespoek A; Jaeger U; Formanek M; Chott A
    Clin Cancer Res; 2005 May; 11(9):3349-52. PubMed ID: 15867234
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
    LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; GariƩpy J
    Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.